Page 338 - MEGIN Book Of Abstracts - 2023

Neural Pathways , 12, 28, 48, 59, 95, 76, 176, 211, Brain Neoplasms 41, 42, 43, 44, 45, 46, 47, 48,
215, 220, 229, 258, 272, 248, 10, 89, 187, 223, 49, 50, 51
297
Neural Pathways
Afferent Pathways 194
Afferent Pathways
Default Mode Network 12, 28, 95, 97, 247, 258,
10, 193, 234 Visual Pathways 12, 28, 97, 235

Efferent Pathways 235 Neurobehavioral Manifestations

Neurons 56, 71, 267 Communication Disorders

Dopaminergic Neurons 218 Language Disorders 218

Interneurons 277 Intellectual Disability

Pyramidal Cells 277 Down Syndrome 72

Nervous System Diseases Prader-Willi Syndrome 221

Central Nervous System Diseases Perceptual Disorders

Movement Disorders 214 Hallucinations 274

Nervous System Malformations 292 Phantom Limb 241, 242, 248

Malformations of Cortical Development 136, Neurocognitive Disorders
164
Cognition Disorders
Neurodegenerative Diseases 3, 55, 60
Cognitive Dysfunction 37, 91, 54, 55, 115, 56,
Neurologic Manifestations 57, 59, 61, 63, 64, 65, 66, 68, 69, 70, 72, 75, 77,
78, 79, 80, 92, 212, 233, 234, 212, 214, 217,
Paresis 285 234, 83, 86, 275

Seizures 113, 114, 116, 119, 120, 121, 122, 128, Neurodevelopmental Disorders
130, 132, 133, 134, 135, 141, 144, 145, 153,
159, 163, 165, 172, 174, 180, 183, 187, 188, Attention Deficit and Disruptive Behavior Disor-
197 ders

Sensation Disorders 18 Attention Deficit Disorder with Hyperactivity
12, 13, 28
Nervous System Neoplasms
Child Development Disorders, Pervasive
Central Nervous System Neoplasms

 ontents  Index 317
C